RU93047799A - COMPOSITIONS CONTAINING RETAIC ACIDS AND TOKOFEROL - Google Patents

COMPOSITIONS CONTAINING RETAIC ACIDS AND TOKOFEROL

Info

Publication number
RU93047799A
RU93047799A RU93047799/14A RU93047799A RU93047799A RU 93047799 A RU93047799 A RU 93047799A RU 93047799/14 A RU93047799/14 A RU 93047799/14A RU 93047799 A RU93047799 A RU 93047799A RU 93047799 A RU93047799 A RU 93047799A
Authority
RU
Russia
Prior art keywords
acids
retaic
tokoferol
compositions containing
retinoic
Prior art date
Application number
RU93047799/14A
Other languages
Russian (ru)
Other versions
RU2111745C1 (en
Inventor
Фидлер Наги Криста
Варингтон Квик Тимоти
Сеймур Шапиро Станли
Original Assignee
Ф.Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/911,606 external-priority patent/US5252604A/en
Application filed by Ф.Хоффманн-Ля Рош Аг filed Critical Ф.Хоффманн-Ля Рош Аг
Publication of RU93047799A publication Critical patent/RU93047799A/en
Application granted granted Critical
Publication of RU2111745C1 publication Critical patent/RU2111745C1/en

Links

Claims (1)

Предлагаемые композиции ретиноевых кислот и токоферолов могут быть использованы для местного применения, не вызывая кожных раздражений, характерных для ретиноевой кислоты.The proposed compositions of retinoic acids and tocopherols can be used for topical administration without causing skin irritations characteristic of retinoic acid.
RU93047799A 1992-07-10 1993-07-06 Liquid composition for local using RU2111745C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/911,606 US5252604A (en) 1992-07-10 1992-07-10 Compositions of retinoic acids and tocopherol for prevention of dermatitis
US911.606 1992-07-10

Publications (2)

Publication Number Publication Date
RU93047799A true RU93047799A (en) 1996-03-20
RU2111745C1 RU2111745C1 (en) 1998-05-27

Family

ID=25430554

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93047799A RU2111745C1 (en) 1992-07-10 1993-07-06 Liquid composition for local using

Country Status (14)

Country Link
US (1) US5252604A (en)
EP (1) EP0578077B1 (en)
JP (1) JPH0751490B2 (en)
CN (1) CN1051704C (en)
AT (1) ATE184192T1 (en)
AU (1) AU666949B2 (en)
CA (1) CA2098550A1 (en)
DE (1) DE69326292T2 (en)
DK (1) DK0578077T3 (en)
ES (1) ES2137209T3 (en)
GR (1) GR3031900T3 (en)
NZ (1) NZ248069A (en)
RU (1) RU2111745C1 (en)
ZA (1) ZA934778B (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5431913A (en) * 1992-01-24 1995-07-11 Phillips; Eva J. Skin cleansing and exfoliant composition and method of treating skin
WO1995003028A1 (en) * 1993-07-23 1995-02-02 Morris Herstein Cosmetic, skin-renewal stimulating composition with long-term irritation control
JP2742333B2 (en) * 1994-05-06 1998-04-22 アルコン ラボラトリーズ，インコーポレイテッド Use of vitamin E tocopheryl derivatives in ophthalmic compositions
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US5853768A (en) * 1995-03-01 1998-12-29 Altadonna; James Topical preparation and method for pain relief
FR2738743B1 (en) * 1995-09-19 1997-11-14 Oreal USE OF ASCORBIC ACID AS AN ACTIVE INGREDIENT FOR THE TREATMENT OF SEBORRHEA IN A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION
US5738856A (en) * 1995-11-03 1998-04-14 Ocular Research Of Boston, Inc. Skin care preparation and method
US5690947A (en) * 1996-08-30 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Borage seed oil as an anti-irritant in compositions containing hydroxy acids or retinoids
US5855893A (en) * 1997-02-14 1999-01-05 Elizabeth Arden Co., Division Of Conopco, Inc. Trichodesma lanicum seed extract as an anti-irritant in compositions containing hydroxy acids or retinoids
DE19820392A1 (en) * 1998-05-07 1999-11-11 Beiersdorf Ag Skin care products containing active ingredient combinations
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
AU767558B2 (en) 1999-09-16 2003-11-13 Mitsubishi Tanabe Pharma Corporation Aromatic nitrogenous six-membered ring compounds
AU2001289438A1 (en) 2000-09-22 2002-04-02 Galephar M/F Pharmaceutical semi-solid composition of isotretinoin
JP4759182B2 (en) * 2001-08-03 2011-08-31 花王株式会社 Water-soluble ginger extract
AU2002327517B2 (en) * 2001-08-21 2008-04-17 Johnson & Johnson Consumer Companies, Inc. Tocopherol enriched compositions and amelioration of inflammatory symptoms
US20030144219A1 (en) * 2001-11-15 2003-07-31 Phinney Stephen Dodge Formulations and methods for treatment or amelioration of inflammatory conditions
DE10162727A1 (en) * 2001-12-20 2003-07-10 Henkel Kgaa New alkaline protease from Bacillus gibsonii (DSM 14391) and washing and cleaning agents containing this new alkaline protease
DE10233740A1 (en) * 2002-07-24 2004-02-05 Basf Ag Preparations containing retinoids
EP1663121B1 (en) * 2003-09-15 2008-08-13 Unilever Plc Method of straightening hair with compositions comprising an alpha-hydroxy acid and a reducing agent
CA2545788A1 (en) * 2003-11-13 2005-06-02 Galileo Pharmaceuticals, Inc. Plant-derived protein extract compositions and methods
CA2556503A1 (en) * 2004-02-19 2005-09-01 Occell Inc. Topical formulations for the treatment of skin conditions
US7662855B2 (en) * 2004-05-11 2010-02-16 Imaginative Research Associates, Inc. Retinoid solutions and formulations made therefrom
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
US7399493B2 (en) * 2004-07-16 2008-07-15 Wille John J Anti-irritant botanicals
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
CA2580329C (en) 2004-09-13 2015-01-06 Chrono Therapeutics Inc. Biosynchronous transdermal drug delivery
SG155959A1 (en) 2004-09-28 2009-10-29 Chemaphor Inc Compositions and methods for promoting weight gain and feed conversion
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
DK2214656T3 (en) * 2007-10-26 2019-03-25 Avivagen Inc COMPOSITIONS AND PROCEDURES TO ENHANCE IMMUNE RESPONSE
KR101709489B1 (en) * 2008-12-22 2017-02-23 존슨 앤드 존슨 컨슈머 홀딩스 프랑스 A composition comprising a retinoid and method of treating skin conditions
ES2813909T3 (en) 2009-04-30 2021-03-25 Avivagen Inc Methods and compositions to improve the health of animals
US10022348B2 (en) 2009-05-20 2018-07-17 Sun Pharmaceutical Industries Limited Topical solution of isotretinoin
CN102458362A (en) 2009-05-20 2012-05-16 兰贝克赛实验室有限公司 Topical retinoid solutions
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US9078925B2 (en) 2012-06-18 2015-07-14 Galephar Pharmaceutical Research, Inc. Pharmaceutical semi-solid composition of isotretinoin
CN104755128B (en) * 2012-11-02 2018-05-11 考司美德制药株式会社 Retinoic acid micropin
CN109568166B (en) 2012-12-14 2022-01-28 宝洁公司 Fragrance materials
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
US20140273055A1 (en) * 2013-03-15 2014-09-18 The Procter & Gamble Company Noninvasive method for measuring oxidative stress and oxidative damage from skin: oxidative stress and oxidative damage biomarkers
US20150184111A1 (en) * 2013-12-26 2015-07-02 Jose A. Rodriguez Perfume and use thereof
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
JP2018511127A (en) 2015-03-12 2018-04-19 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． Craving input and support system
AU2016346203B2 (en) 2015-10-30 2021-05-27 Leo Pharma A/S Isotretinoin formulations and uses and methods thereof
JP2020503950A (en) 2017-01-06 2020-02-06 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． Device and method for transdermal drug delivery
AU2019279884A1 (en) 2018-05-29 2020-12-10 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1466062A (en) * 1974-04-09 1977-03-02 Knight K Cosmetic preparations
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4487782A (en) * 1982-03-26 1984-12-11 Ortho Pharmaceutical Corporation Topical treatment of non-inflammatory acne
JPS61207332A (en) * 1985-03-12 1986-09-13 Nisshin Kagaku Kk Remedy for dermatic disease
US4843096A (en) * 1985-06-26 1989-06-27 Stiefel Laboratories, Inc. Treatment of acne
FR2591105B1 (en) * 1985-12-11 1989-03-24 Moet Hennessy Rech PHARMACEUTICAL COMPOSITION, IN PARTICULAR DERMATOLOGICAL, OR COSMETIC, BASED ON HYDRATED LIPID LAMELLAR PHASES OR LIPOSOMES CONTAINING A RETINOIDE OR A STRUCTURAL ANALOG OF SUCH A RETINOID AS A CAROTENOID.
US4900550A (en) * 1987-08-19 1990-02-13 Amy Allene Cosmetiques, Inc. Skin care cosmetic regime

Similar Documents

Publication Publication Date Title
RU93047799A (en) COMPOSITIONS CONTAINING RETAIC ACIDS AND TOKOFEROL
FR2634376B1 (en) NOVEL SOLID AND POROUS UNIT FORM COMPRISING MICROPARTICLES AND / OR NANOPARTICLES, AS WELL AS ITS PREPARATION
CA2081269A1 (en) Penetration enhancement of topically applied formulations
ZA885192B (en) Pharmaceutical preparations
IE940583L (en) Topical antimicrobial pharmaceutical compositions
DE69319440T2 (en) PRODUCTION OF PHARMACEUTICAL COMPOSITIONS CONTAINING CALCITONIN
IE790756L (en) Cerebral therapeutic agent
DK0582239T3 (en) Pharmaceutical and / or cosmetic formulation
AU674142B2 (en) Use of cosmetic composition
CA2140545A1 (en) Use of first runnings coconut fatty acid as insect-repellent
KR920701213A (en) Methylenediphosphonic acid compound and anti-inflammatory agent using it as an active ingredient
DE69419981T2 (en) Agent containing retinoid
DK0700898T3 (en) L-carnitine salt and cosmetic and pharmaceutical preparations containing the same, for the treatment of dermatoses.
FR2598320B1 (en) WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS CONTAINING UBIQUINONE AS ACTIVE INGREDIENT USEFUL IN DIFFERENT THERAPEUTIC APPLICATIONS
KR900014382A (en) (S) -7- (3-amino-1-pyrrolidinyl) -1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-naphthyridine-3-carboxylic acid
DK0437225T3 (en) Topical preparations
NO902104L (en) COSMETIC MIXING.
CA2113080A1 (en) Topical composition containing penciclovir
NO931009D0 (en) USE OF 7-OXO-7H-PYRIDO (1,2,3-DE) (1,4) BENZOXACIN-6-CARBONIC ACIDS AND ESTES AS PHARMACEUTICALS
FR2607005B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING URSODESOXYCHOLIC ACID
FI871695A0 (en) TOPISKA, CARDIOVASCULAERA PRODUCT.
NO863005D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,4,5,6,7,8-HEXSAHYDRO-2-ALKYL-4-ARYL-5-OXO-1,7-NAFTYRIDINE-3-CARBOXYL ACID ESTER DERIVATIVES.
KR910007540A (en) Prevention and treatment of blood cell reduction disorder
IT1233861B (en) COMPOSITION OF COMPOUNDS THAT IMPROVE ANALGESIC, ANTIPIRETIC AND ANTI-INFLAMMATORY ACTIVITIES
IT1233426B (en) PHARMACEUTICAL COMPOSITIONS FOR ORAL USE WITH SEQUESTRANT ACTIVITY OF BILE ACIDS CONTAINING COLESTYRAMIN AS THE ACTIVE INGREDIENT, AND PROCEDURE TO PREPARE THEM